A clinical trial to study the effects of two skin antibiotic preparations, Mupirocin and Medihoney applied at the catheter exit site of peritoneal dialysis patients
Phase 2
- Conditions
- Health Condition 1: null- Prevention of Infection at Tenckhoff Exit Site in Peritoneal Dialysis Patients
- Registration Number
- CTRI/2011/08/001971
- Lead Sponsor
- Royal Brisbane Hospital Queensland Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 440
Inclusion Criteria
?Chronic Kidney Disease stage 5 patients aged 18 years or older on PD
?Incident and prevalent PD patients willing to provide informed consent
Exclusion Criteria
?History of psychological illness or condition that interferes with ability to understand or comply with the requirements of the study;
?Recent (within 1 month) ESI, peritonitis, or tunnel infection;
?Known hypersensitivity to, or intolerance of, honey or mupirocin;
?Current or recent (within 4 weeks) treatment with an antibiotic administered by any route
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method